Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

This article is part of the supplement: 25th European Workshop for Rheumatology Research

Poster presentation

Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrin

I Auger1, M Sebag2, C Vincent2, S Guis1, L Nogueira2, B Svensson3, A Cantagrel4, G Serre2 and J Roudier1

Author affiliations

1 INSERM UMR 639, Medical School and Rheumatology Ward, La Conception Hospital, Marseille, France

2 CNRS-Toulouse III University UMR 5165, Purpan Hospital, Toulouse, France

3 Rheumatology Ward, Helsingborg Lasarett AB, Helsingborg, Sweden

4 Toulouse III University EA 2405 and Rheumatology Ward, Rangueil Hospital, Toulouse, France

For all author emails, please log on.

Citation and License

Arthritis Research & Therapy 2005, 7(Suppl 1):P63  doi:10.1186/ar1584

The electronic version of this article is the complete one and can be found online at:


Received:11 January 2005
Published:17 February 2005

© 2005 BioMed Central Ltd

Poster presentation

Rheumatoid arthritis (RA), a chronic inflammatory joint disease, develops in patients expressing particular HLA-DR alleles. RA patients' sera contain antibodies to a post-translationally modified form of fibrin on which arginyl residues are transformed in citrullins.

We tested whether HLA-DR alleles influence the production of anti-citrullinated fibrin antibodies in RA patient sera and whether the replacement of arginyl residues by citrullyl residues on fibrin peptides could modify their binding to RA-associated HLA-DR molecules and their recognition by T cells in RA patients and controls.

We found that RA-associated HLA-DR alleles are also associated with presence of anti-citrullinated fibrin antibodies in RA patient sera. Multiple peptides from the alpha and beta chain of fibrin are capable to bind many HLA-DR alleles. RA-associated HLA-DR alleles are good fibrin peptide binders. However, citrullination does not influence fibrin peptide binding to HLA-DR or fibrin peptide recognition by T cells.

Finally, peripheral blood T cells that recognize native or citrullinated fibrin peptides are common in RA patients and very uncommon in normal controls.

These results suggest that citrullination of fibrin has nothing to do with peptide/HLA-DR/T cell interaction and is merely involved in the definition of B-cell epitopes.